These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 13852757)

  • 1. [On the activation of fibrinolysis by administration of nicotinic acid].
    IMHOF P; IMHOF M; EICHENBERGER E; LAUENER H
    Schweiz Med Wochenschr; 1959 Jul; 89():736-40. PubMed ID: 13852757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various trials on the effect of nicotinic acid and Complamin on fibrinolysis].
    MOERS AM; den OTTOLANDER GJ
    Ned Tijdschr Geneeskd; 1962 Jun; 106():1221-5. PubMed ID: 14475011
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the fibrinolytic and circulatory effect of nicotinic acid with special reference to its therapeutic usefulness].
    EGLI H; KLENSCH H
    Med Welt; 1961 Oct; 41():2108-13. PubMed ID: 13889445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activation of fibrinolysis with Complamin].
    FISCHBACHER W
    Ther Umsch; 1961 Nov; 18():452-9. PubMed ID: 13893098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic action of nicotinic acid].
    MARRAZZA P; LUCA S
    Acta Vitaminol; 1960 Oct; 14():207-9. PubMed ID: 13767111
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity.
    WILSON WL; FOSTIROPOULOS G
    Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the mechanism of action of nicotinic acid on blood coagulation and fibrinolysis].
    SAILER S
    Wien Z Inn Med; 1960 Aug; 41():307-16. PubMed ID: 13745428
    [No Abstract]   [Full Text] [Related]  

  • 8. [On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy].
    SAILER S; EBER O
    Klin Wochenschr; 1960 Jun; 38():548-51. PubMed ID: 14440816
    [No Abstract]   [Full Text] [Related]  

  • 9. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activation of fibrinolysis by 3-pyridylacetic acid and nicotinic acid in man].
    GIBELLI A; SACCHETTI G; MAINIERI L; SOARDI F
    Acta Vitaminol; 1962; 16():107-19. PubMed ID: 13947690
    [No Abstract]   [Full Text] [Related]  

  • 12. THE INFLUENCE OF AN INCREASED PLASMA FIBRINOLYTIC ACTIVITY ON THE PROTEIN PATTERN.
    BOGDANIKOWA B; BIELAWIEC M
    Sangre (Barc); 1964; 61():37-40. PubMed ID: 14214882
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 14. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.
    MCNICOL GP; DOUGLAS AS
    Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517
    [No Abstract]   [Full Text] [Related]  

  • 15. [RESEARCH ON INFLUENCE OF VASCULO-TISSUE FACTORS ON COAGULATION AND FIBRINOLYSIS. VI. LOCAL ACTIVATION AND GENERAL ACTIVATION OF FIBRINOLYSIS DIVERSITY OF RESPONSIBLE FACTORS].
    NERISERNERI GG; ROSSIFERRINI PL; PAOLETTI P; SILVESTRINI E
    Riv Crit Clin Med; 1964 Dec; 64():630-40. PubMed ID: 14320090
    [No Abstract]   [Full Text] [Related]  

  • 16. PHYSIOLOGY AND PHARMACOLOGY OF FIBRINOLYSIS.
    FEARNLEY GR
    Br Med Bull; 1964 Sep; 20():185-8. PubMed ID: 14216084
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of hepatic DPN in the rat after the administration of nicotinic acid and the nicotinic hexaester of inositol].
    CHIARINI P; MELANI F
    Sperimentale; 1962; 112():74-9. PubMed ID: 13878906
    [No Abstract]   [Full Text] [Related]  

  • 18. [VALUE OF THROMBELASTOGRAPHY IN THERAPEUTIC FIBRINOLYSIS OBTAINED USING A NICOTINIC ACID DERIVATIVE].
    PERRETTA A; PARANO JR; VILLA JJ
    Prensa Med Argent; 1964 Aug; 51():427-31. PubMed ID: 14193347
    [No Abstract]   [Full Text] [Related]  

  • 19. [FURTHER THERAPEUTIC POSSIBILITIES FOR PERIPHERAL CIRCULATION DISTURBANCES WITH SPECIAL REGARD TO FIBRINOLYSIS ACTIVATION].
    LUCZAK S
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1964 Nov; 308():841-3. PubMed ID: 14347791
    [No Abstract]   [Full Text] [Related]  

  • 20. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.
    FLETCHER AP; BIEDERMAN O; MOORE D; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1964 Apr; 43(4):681-95. PubMed ID: 14149921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.